We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+24.15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$153M
AUM Growth
+$25.8M
Cap. Flow
+$5.34M
Cap. Flow %
3.49%
Top 10 Hldgs %
66%
Holding
76
New
20
Increased
15
Reduced
12
Closed
14

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.3M
2
ASTS icon
AST SpaceMobile
ASTS
+$3.79M
3
ABVX
Abivax
ABVX
+$2.95M
4
PVLA
Palvella Therapeutics
PVLA
+$2.73M
5
ARWR icon
Arrowhead Research
ARWR
+$2.04M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$5.05M
2
KRYS icon
Krystal Biotech
KRYS
+$4.62M
3
CELC icon
Celcuity
CELC
+$3.41M
4
AAOI icon
Applied Optoelectronics
AAOI
+$3.23M
5
ALMS
Alumis Inc
ALMS
+$2.85M

Sector Composition

Rank Sector Weight
1 Healthcare 63.9%
2 Energy 17.83%
3 Technology 7.89%
4 Consumer Discretionary 4.98%
5 Industrials 1.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONDS icon
51
Ondas Inc
ONDS
$5.05B
$309K 0.2%
37,500
– –
APC
52
ARKO Petroleum
APC
$944M
$283K 0.18%
15,000
– –
RYZ
53
Ryerson Holding Corp
RYZ
$1.43B
$276K 0.18%
11,200
+400
+4% +$10.6K
WGS icon
54
GeneDx Holdings
WGS
$2.08B
$275K 0.18%
4,000
-4,000
-50% -$227K
MU icon
55
Micron Technology
MU
$1.01T
$231K 0.15%
200
-1,300
-87% -$975K
NKLR
56
Terra Innovatum Global N.V.
NKLR
$636M
$221K 0.14%
45,000
– –
VIVO
57
VivoPower PLC
VIVO
$116M
$220K 0.14%
+42,500
New +$175K
SPCX
58
SpaceX
SPCX
$1.43T
$137K 0.09%
+800
New +$136K
LSPD icon
59
Lightspeed Commerce
LSPD
$1.34B
$131K 0.09%
12,500
– –
SSYS icon
60
Stratasys
SSYS
$778M
$85.6K 0.06%
10,000
– –
PDSB icon
61
PDS Biotechnology
PDSB
$40.6M
$26.4K 0.02%
30,000
– –
AMLX icon
62
Amylyx Pharmaceuticals
AMLX
$2.43B
– –
-9,000
Closed -$125K
CAPR icon
63
Capricor Therapeutics
CAPR
$228M
– –
-5,000
Closed -$152K
ESPR
64
DELISTED
Esperion Therapeutics
ESPR
– –
-47,500
Closed -$130K
HIMS icon
65
Hims & Hers Health
HIMS
$7.33B
– –
-2,500
Closed -$51.9K
INCY icon
66
Incyte
INCY
$24.3B
– –
-2,000
Closed -$188K
LITE icon
67
Lumentum
LITE
$64.3B
– –
-900
Closed -$632K
LTRX icon
68
Lantronix
LTRX
$263M
– –
-15,000
Closed -$78.6K
NVDA icon
69
NVIDIA
NVDA
$5.31T
– –
-2,800
Closed -$488K
OLMA icon
70
Olema Pharmaceuticals
OLMA
$1.01B
– –
-25,000
Closed -$373K
REPL icon
71
Replimune Group
REPL
$994M
– –
-61,500
Closed -$470K
S icon
72
SentinelOne
S
$7.2B
– –
-54,300
Closed -$699K
STAA icon
73
STAAR Surgical
STAA
$1.14B
– –
-55,500
Closed -$1.04M
VPG icon
74
Vishay Precision Group
VPG
$978M
– –
-3,000
Closed -$130K
CRCL
75
Circle Internet Group
CRCL
$15.7B
– –
-6,000
Closed -$572K
1 2
3

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, ACT Capital Management held 76 positions worth $153M, up 20% from $127M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

ACT Capital Management deployed $5.34M of net new capital in Q2 2026, opening 20 new positions and adding to 15 existing holdings. Its largest new stake was Tesla: 10,800 shares worth $4.54M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 62% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Amazon, an estimated $5.05M trimmed.

  • ACT Capital Management's largest Q2 2026 buy was Tesla: 10,800 shares worth $4.54M.
  • ACT Capital Management added most to Abivax in Q2 2026, an estimated $2.95M increase.
  • ACT Capital Management's biggest Q2 2026 reduction was Amazon, cutting an estimated $5.05M.
  • ACT Capital Management fully exited STAAR Surgical in Q2 2026, selling an estimated $1.04M.
  • ACT Capital Management's ten largest holdings make up 66% of its $153M portfolio in Q2 2026.
  • ACT Capital Management opened 20 new positions and closed 14 in Q2 2026.
  • ACT Capital Management's portfolio value rose 20% quarter-over-quarter to $153M.

Based on ACT Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.